2018
DOI: 10.1016/j.bios.2017.11.049
|View full text |Cite
|
Sign up to set email alerts
|

Selective isolation and noninvasive analysis of circulating cancer stem cells through Raman imaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
51
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 58 publications
(52 citation statements)
references
References 70 publications
1
51
0
Order By: Relevance
“…Raman spectrum by SERS analysis of the MDA-MB-231 and MCF-7 exhibited different shapes and peaks so the classification of the cells could be relatively easy with the nondestructive method by measurement of Raman spectrum. Noninvasive analysis of the circulating cancer stem cells (CCSCs) was successfully conducted with microfluidic chips and Raman reporter-labelled Au nanoparticles [116] (Figure 4b). Solution-based analyte with several cells was flown into the cell and micropillars separated circulating cells and other small biomolecules.…”
Section: Sers-based Analytical Platform With Metallic Nanostructures mentioning
confidence: 99%
See 1 more Smart Citation
“…Raman spectrum by SERS analysis of the MDA-MB-231 and MCF-7 exhibited different shapes and peaks so the classification of the cells could be relatively easy with the nondestructive method by measurement of Raman spectrum. Noninvasive analysis of the circulating cancer stem cells (CCSCs) was successfully conducted with microfluidic chips and Raman reporter-labelled Au nanoparticles [116] (Figure 4b). Solution-based analyte with several cells was flown into the cell and micropillars separated circulating cells and other small biomolecules.…”
Section: Sers-based Analytical Platform With Metallic Nanostructures mentioning
confidence: 99%
“…(b) Raman-active nanoprobe-based chip platform with the capability of simultaneous detection, isolation, and further analysis of circulating cancer stem cells (CCSCs) and various circulating tumor cells (CTCs) subtypes though Raman imaging. Reproduced with permission[116]. Copyright 2018, ACS Publications.…”
mentioning
confidence: 99%
“…This Raman barcoding system provides the potential to overcome a “multiplexing ceiling” from existing optical materials. Cho and his coworkers developed a Raman barcoding-based biosensor with GNPs to diagnose and analyze circulating cancer stem cells (CCSCs) in the presence of circulating tumor cells (CTCs) ( Figure 2 C) [ 42 ]. For this approach, five different combinations of Raman-active nanoprobes (RANs) were prepared, each consisting of a GNP (as a Raman signal enhancer), aromatic thiol (as a Raman reporter), antibodies, and thiolated DNA (as a capturing linker).…”
Section: Gold Nanoparticle-based Surface-enhanced Raman Spectroscomentioning
confidence: 99%
“…( A ) Highly ordered octahedral gold nanoparticle (GNP) arrays for Raman signal enhancement; ( B ) pH-dependent SERS signal differences between serotonin and tryptophan based on gold nanoparticles; ( C ) Raman barcoding-based cancer subtyping platform based on combination of Raman reporter tagged gold nanoparticles; ( D ) detection of glucose in live mouse tissue based on dimerization of gold nanoparticles. ( A ) Figure reproduced with permission from [ 37 ], © 2011 Elsevier; ( B ) Figure reproduced with permission from [ 38 ], © 2010 Society of Photo-Optical Instrumentation Engineers; ( C ) Figure reproduced with permission from [ 42 ], © 2018 Elsevier; ( D ) Figure reproduced with permission from [ 43 ], © 2017 American Chemical Society.…”
Section: Figurementioning
confidence: 99%
“…Furthermore, the combination of the great intensity of the signals obtained with this technique with the latest developments in the fields of microfluidics and optical spectroscopy (2D charge-coupled devices (CCDs)), enables real time (i.e., online) monitoring of continuous flows. In fact, online SERS detection has been already demonstrated using microfluidic devices for a number of analytes including pesticides and metals in water, explosives and pollutants, drugs, cancer cells and metabolites, and many others [ 26 , 29 , 30 , 31 , 32 , 33 ]. Therefore, the concurrent rise of SERS and microfluidic technologies in recent years is more of an expected result than coincidence.…”
Section: Introductionmentioning
confidence: 99%